1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;
2. Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biology and Therapy. 2005.
3. Taylor RC, Cullen SP, Martin SJ. Apoptosis: Controlled demolition at the cellular level. Nature Reviews Molecular Cell Biology. 2008.
4. Häcker G. The morphology of apoptosis. Cell and Tissue Research. 2000.
5. Hongmei Z. Extrinsic and Intrinsic Apoptosis Signal Pathway Review. In: Apoptosis and Medicine. 2012.
6. Bratton SB, Walker G, Srinivasula SM, Sun XM, Butterworth M, Alnemri ES, et al. Recruitment, activation and retention of caspases-9 and-3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J. 2001;
7. Tirmomenin M, Ataei F, Hosseinkhani S. Cloning of human survivin in pET-28a and its protein expression study in E.coli BL21(DE3). Modares J Biotechnol [Internet]. 2020 Oct 10 [cited 2021 Apr 25];11(3):0–0. Available from: https://biot.modares.ac.ir/article-22-41661-en.html
8. Mehdizadeh K, Ataei F, Hosseinkhani S. Effects of doxorubicin and docetaxel on susceptibility to apoptosis in high expression level of survivin in HEK and HEK-S cell lines as in vitro models. Biochem Biophys Res Commun. 2020;
9. Mahmood T, Yang PC. Western blot: Technique, theory, and trouble shooting. N Am J Med Sci. 2012;
10. Bian X, Giordano TD, Lin HJ, Solomon G, Castle VP, Opipari AW. Chemotherapy-induced Apoptosis of S-type Neuroblastoma Cells Requires Caspase-9 and Is Augmented by CD95/Fas Stimulation. J Biol Chem. 2004;
11. Mehdizadeh K, Ataei F, Hosseinkhani S. Treating MCF7 breast cancer cell with proteasome inhibitor Bortezomib restores apoptotic factors and sensitizes cell to Docetaxel. Med Oncol. 2021;
12. Silke J, Hawkins CJ, Ekert PG, Chew J, Day CL, Pakusch M, et al. The anti-apoptotic activity of XIAP is retained upon mutation of both the caspase 3- and caspase 9-interacting sites. J Cell Biol. 2002;